Literature DB >> 26961977

Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.

Hamlin Emory1, Neptune Mizrahi2.   

Abstract

Entities:  

Keywords:  absolute power; low resolution electromagnetic tomography; monoamine oxidase inhibitors; quantitative electroencephalography; type 1 diabetes

Mesh：

Substances：

Year:  2016        PMID： 26961977      PMCID： PMC5032945          DOI： 10.1177/1932296816638106

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  4 in total

1.  Monoamine oxidase inhibitors revisited: what you should know.

Authors:  Joseph F Goldberg; Michael E Thase
Journal:  J Clin Psychiatry       Date:  2013-02       Impact factor: 4.384

2.  Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.

Authors:  Andre Kleinridders; Weikang Cai; Laura Cappellucci; Armen Ghazarian; William R Collins; Sara G Vienberg; Emmanuel N Pothos; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

3.  Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort.

Authors:  Shane M Coleman; Wayne Katon; Elizabeth Lin; Michael Von Korff
Journal:  Psychosomatics       Date:  2013-06-04       Impact factor: 2.386

Review 4.  Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.

Authors:  Katharine Barnard; Robert C Peveler; Richard I G Holt
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.